LSI Segment Divestment
Our Business in the COVID-19 Pandemic
Our work to control and contain the pandemic
Business continuity maintained through rigorous
protection measures and due to our classification as
an essential supplier
LPBN is working to support a broad range of customers.
developing vaccine candidates, treatments and
therapies related to COVID-191
Sixteen microbial control solutions produced by LSI
were approved by US EPA² to eradicate COVID-19 on
surfaces
AstraZeneca
moderna
00000
君实生物
TopAlliance
༠༩
Humanigen
altimmune
The logos constitute a selection of customers who are collaborating with Lonza on COVID-19 projects. In total, Lonza has received more than 200 enquiries related to COVID-19 projects
2 United States Environmental Protection Agency
10View entire presentation